Bridgefront Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$421K Buy
+16,313
New +$353K 0.1% 313

Other funds holding AMPH

Bridgefront Capital's AMPH Position: Q3 2026 in Review

Bridgefront Capital opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2026: 16,313 shares worth $421K. The stake represents 0.1% of the portfolio and ranks #313 among its holdings.

227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Bridgefront Capital held 16,313 shares of Amphastar Pharmaceuticals worth $421K as of Q3 2026.
  • Amphastar Pharmaceuticals was a new Bridgefront Capital position in Q3 2026.
  • Amphastar Pharmaceuticals made up 0.1% of Bridgefront Capital's portfolio in Q3 2026, its #313 holding.
  • 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Bridgefront Capital's 13F filing for Q3 2026, filed 16 Nov 2026.